Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Moclobemide
Drug ID BADD_D01483
Description A reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder. Most meta-analyses and most studies indicate that in the acute management of depression, moclobemide is more efficacious than placebo medication and similarly efficacious as tricyclic antidepressants (TCA) or selective serotonin reuptake inhibitors (SSRIs). Due to negligible anticholinergic and antihistaminic actions, moclobemide has been better tolerated than tri- or heterocyclic antidepressants [A3901].
Indications and Usage For the treatment of major depressive disorder and bipolar disorder [A31901].
Marketing Status approved; investigational
ATC Code N06AG02
DrugBank ID DB01171
KEGG ID D02561
MeSH ID D020912
PubChem ID 4235
TTD Drug ID D01ZSO
NDC Product Code Not Available
UNII PJ0Y7AZB63
Synonyms Moclobemide | Moclobamide | Apo-Moclobemide | Apo Moclobemide | Arima | Aurorix | Manerix | Moclamine | Aurorex | Chem mart Moclobemide | Moclobemide, Chem mart | DBL Moclobemide | Moclobemide, DBL | Deprenorm | Feraken | GenRX Moclobemide | Moclobemide, GenRX | Healthsense Moclobemide | Moclobemide, Healthsense | Moclix | Terry White Chemists Moclobemide | Moclobemid Stada | Stada, Moclobemid | Moclobemid von ct | von ct, Moclobemid | Moclobemid-1A Pharma | Moclobemid 1A Pharma | Moclobemid1A Pharma | Moclobemid-Puren | Moclobemid Puren | Moclobemid-ratiopharm | Moclobemid ratiopharm | Moclobeta | Moclodura | Moclonorm | Nu-Moclobemide | Nu Moclobemide | NuMoclobemide | PMS-Moclobemide | PMS Moclobemide | Rimoc | Ro 11-1163 | Ro 11 1163 | Ro-11-1163 | Novo-Moclobemide | Novo Moclobemide | NovoMoclobemide | Moclobemid AZU | AZU, Moclobemid
Chemical Information
Molecular Formula C13H17ClN2O2
CAS Registry Number 71320-77-9
SMILES C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dysgeusia07.14.03.001; 17.02.07.003--
Dyspepsia07.01.02.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Dysuria20.02.02.002--
Extrasystoles02.03.02.003---
Eye pain06.08.03.002--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014---
Feeling cold08.01.09.008---
Flat affect19.04.01.004---
Flatulence07.01.04.002--
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Gastritis07.08.02.001--
Gastrointestinal pain07.01.05.005--
Gingivitis07.09.10.002; 11.01.04.013--
Hallucination19.10.04.003--
Headache17.14.01.001--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypertension24.08.02.001--
Hypotension24.06.03.002--
Insomnia17.15.03.002; 19.02.01.002--
Irritability08.01.03.011; 19.04.02.013--
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.004--
Loss of consciousness17.02.04.004---
Malaise08.01.01.003--
Menopausal symptoms21.02.02.002---
Migraine17.14.02.001; 24.03.05.003---
Muscle contractions involuntary15.05.03.008; 17.05.03.001---
Myalgia15.05.02.001--
Nausea07.01.07.001--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages